CARBOGEN AMCIS announces two successful FDA inspections at its manufacturing sites in Neuland and Aarau, Switzerland. Read the full press release here:

We are thrilled to publish the first teaser of our latest customer testimonial video, showcasing the valuable partnership between @MedinCell and CARBOGEN AMCIS. Full video:.🔗 Thank you again to the MedinCell team for their trust. #cdmo #drugproduct

CARBOGEN AMCIS announced the opening of a new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France. Click on the link below to read the full press release. ➡ #drugproduct #BringingYourScienceToLife

CARBOGEN AMCIS announces the appointment of Francois Baduel as Vice President of Business Development, Sales & Marketing. Click here to read the full press release.

CARBOGEN AMCIS announces that Pascal Villemagne has been named Chief Executive Officer, effective first of April. In his new role, Pascal Villemagne will be leading CARBOGEN AMCIS and its nine sites around the world. Read more here:

RT @LSZYSN: Check out your career opportunities at CARBOGEN AMICS, an international company with 9 sites around the globe. Working as a ser….

RT @fbonnichon: Il y a 1 an nous posions la première pierre avec ⁦@laurentwauquiez⁩ .Aujourd’hui visite de l’usine déjà sortie de terre ⁦@C….

RT @RLV_agglo: En 2023, nouvelle ligne de production dédiée à la fabrication de produits injectables 💉 à la pointe de la technologie et uni….

We are thrilled to welcome Dr Mara Guzzetti as our new General Manager at CARBOGEN AMCIS Switzerland. Mara takes over the lead of the Swiss CARBOGEN AMCIS entity from Stephan Fritschi, VP Operations, who refocuses on the strategic development of the CARBOGEN AMCIS group.

Dishman Carbogen Amcis Ltd announces successful results on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19. CARBOGEN AMCIS provided the Active Pharmaceutical Ingredient (Calcifediol).

CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland. The pre-approval paper inspection for an intermediate product from a customer was concluded successfully, confirming that no on-site inspection is required. Read more

CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client. Read the full press release here:.

CARBOGEN AMCIS confirms the #acquisition of further property in Bubendorf, Switzerland, where the company's headquarters are located. Click here to learn more 👉

RT @ZymPhil: L'État a annoncé les 36 nouveaux lauréats de l’appel à projets @resilience_2020 volet #Industrie dont 9 en @auvergnerhalpes :….

RT @lamontagne_riom: #PuydeDôme - À #Riom, @CARBOGEN_AMCIS développe des médicaments injectables pour des laboratoires du monde entier. ⏩ht….

(EN) CARBOGEN AMCIS is proud to be one of the 36 new winning projects of the (re)localization part of the economic recovery program. This relocation will directly benefit the local economy and create jobs. @Economie_Gouv .

(FR) CARBOGEN AMCIS est fier de faire partie des 36 nouveaux projets lauréats du volet (re)localisation du plan de relance. Une relocalisation qui bénéficiera directement à l’économie locale et à la création d’emploi. @Economie_Gouv .

We announced today a joint funding agreement of more than CHF 15 million with a long-standing Japan based customer to build a site extension at the Bubendorf site in Switzerland. Learn more and read the news announcement:

Pascal Villemagne, Vice President Sales & Marketing at CARBOGEN AMCIS and President of Riom site, was interviewed for the French show Paroles d'experts about the expansion project of our site in France. Have you watched the interview, yet? Click here 👉.